enGene Therapeutics ENGN
NASDAQ ENGN
$1.56 -0.02 (-1.27%)
At close: Oct 23, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Net Debt Issuances and Repayments (2023 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Net Debt Issuances and Repayments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -2.00 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 enGene Therapeutics 109.41 Mn -885.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2026 25.00 Mn
Jan 31, 2024 22.50 Mn
Jul 31, 2023 30.00 Mn
API Access

enGene Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=ENGN&period=max&api_key=YOUR_API_KEY